계명대학교 의학도서관 Repository

아스피린을 복용하던 급성 뇌경색 환자에서 생화학적 아스피린저항성이 뇌경색의 중증도에 미치는 영향

Metadata Downloads
Author(s)
김지훈김연수손성일조경희Ji Hoon KimYoun Soo KimSung-Il SohnKyung-Hee Cho
Keimyung Author(s)
Sohn, Sung IlCho, Kyung Hee
Department
Dept. of Neurology (신경과학)
Journal Title
대한신경과학회지
Issued Date
2011
Volume
29
Issue
4
Abstract
Background: There are conflicting data in the literature regarding aspirin resistance. This study evaluated the effect of biochemical aspirin resistance on initial stroke severity in acute stroke patients who had taken aspirin.
Methods: We reviewed acute ischemic stroke patients who were already on aspirin. Biochemical aspirin resistance was defined as an aspirin reaction unit score of ≥550, as evidenced by the VerifyNow-Aspirin assay, which was performed after 4 days of continuous aspirin medication. Initial stroke severity was evaluated using National Institutes of Health Stroke Scale (NIHSS) scores at day 4, which were dichotomized into mild (0-7) and severe (≥8). Modified Rankin Scale scores were determined at 3 months. The Alberta Stroke Program Early CT Scores (ASPECTS) were assessed on initial diffusion-weighted imaging (DWI). We examined the relationships between biochemical aspirin resistance and initial stroke severity.
Results: Nine of 106 patients (8.5%) had biochemical aspirin resistance. The initial stroke severity was significantly associated with DWI-ASPECTS (p<0.001), initial C-reactive protein level (p=0.005), biochemical aspirin resistance(p=0.009), and stenosis or occlusion of the relevant artery (p=0.029). Multivariate analysis showed that biochemical aspirin resistance [odds ratio (OR), 15.24; 95% confidence interval (CI), 2.49-93.31; p=0.003] and initial C-reactive protein level (per 1 mg/dL; OR, 2.43; 95% CI, 1.47-4.00; p=0.001) were independently associated with initial stroke severity(NIHSS score ≥8). However, biochemical aspirin resistance was not associated with clinical outcome at 3 months(p=0.366).
Conclusions: Biochemical aspirin resistance was independently associated with initial stroke severity. This suggests that detection of biochemical aspirin resistance in acute ischemic stroke is useful when choosing the optimal treatment.
Alternative Title
Biochemical Aspirin Resistance Affect on Stroke Severity in Acute Stroke Patients Who Had Taken Aspirin
Keimyung Author(s)(Kor)
손성일
조경희
Publisher
School of Medicine
Citation
김지훈 et al. (2011). 아스피린을 복용하던 급성 뇌경색 환자에서 생화학적 아스피린저항성이 뇌경색의 중증도에 미치는 영향. 대한신경과학회지, 29(4), 303–308.
Type
Article
ISSN
1225-7044
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/39369
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Neurology (신경과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.